NGL Fine Chem Ltd Share Price Today - NGL Fine Chem Ltd Stock Price Live NSE/BSE

NGL Fine Chem Ltd

NSE: NGLFINE BSE: 524774

₹2301.20

(-0.14%)

Wed, 11 Mar 2026, 07:26 am

MTF 5xInvest in NGL Fine Chem Ltd with 5x Leverage Buy with MTF

Market Cap14.17B

PE Ratio40.50

Dividend0.08

Health Technology

Pharmaceuticals: Major

24.5K

NGL Fine Chem Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1455.61
Net Profit
21.12
P/B
2.44
Sector P/E
32.36
P/E
32.59
EV/EBITDA
17.50
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.20
ROCE (Industry)
20.50
RONW (Industry)
17.60
ROE
7.75
ROCE
9.33
Debt/Equity
0.20
EPS (TTM)
56.80
Dividend Yield
0.07
Book Value
485.77
Interest Cover
9.50

Analysis

all

Pros

Dividends paid are thoroughly covered by earnings (14.2x coverage).
NGL Fine-Chem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
NGL Fine-Chem is profitable, therefore cash runway is not a concern.
NGL Fine-Chem is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (36.6%, greater than 20% of total debt).

Cons

NGL Fine-Chem only just started paying a dividend, it is too early to tell if payments are increasing.
It is too early to tell whether NGL Fine-Chem has stable dividend payments.
NGL Fine-Chem's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
NGL Fine-Chem's dividend is below the markets top 25% of dividend payers in India (3.08%).
High level of physical assets or inventory.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	72.74	72.74	72.74	72.74	72.74
FII	0	0.00	0.00	0.00	0.04
DII	0	0	0.00	0.00	0.00
Public	27.26	27.26	27.26	27.26	27.22
Government	0	0	0	0	0

Technical Analysis

RSI

63.66

MACD

121.27

50 DMA

1909.92

200 DMA

1473.05

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	4182.90	3163.40	2732.30	2143.90	1712.80	1124.40	104.90
Fibonacci	3163.40	2773.95	2533.35	2143.90	1754.45	1513.85	1124.40
Camarilla	2581.56	2488.11	2394.65	2143.90	2207.75	2114.29	2020.84

Pivots Level: Classic

+2039.00

4182.90

+1019.50

3163.40

+588.40

2732.30

2143.90

Pivot Point

LTP: 2405.80

-431.10

1712.80

-1019.50

1124.40

-2039

104.90

Moving Average

SMAEMA

Period

Value

10-EMA
2335.63
20-EMA
2259.55
30-EMA
2164.71
50-EMA
2003.19
100-EMA
1776.00
200-EMA
1624.44

Announcement Date	Purpose	Action	Ex Date
03 Feb 2026	board-meetings	Quarterly Results
12 Jul 2025	dividend	Final Dividend - Rs. - 1.75	12 Aug 2025
22 May 2025	dividend	₹1.75 Dividend /Share	12 Aug 2025
22 May 2025	agm
16 Jul 2024	dividend	Final Dividend - Rs. - 1.75	16 Aug 2024
21 May 2024	agm
21 May 2024	dividend	₹1.75 Dividend /Share	16 Aug 2024
18 Jul 2023	dividend	Final Dividend - Rs. - 1.75	18 Aug 2023
15 May 2023	dividend	₹1.75 Dividend /Share	18 Aug 2023
15 May 2023	agm

NGL Fine Chem Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Cipla Ltd

Divis Laboratories Ltd

NGL Fine Chem Ltd About

NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. The Group caters to various global companies to custom manufacture high quality pharmaceuticals.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1981

Headquarters

CEO

Dhananjay N Mungale

Employees

Contact

Website

http://www.nglfinechem.com

info@nglfinechem.com

Phone

+91-22-2663 6450

Location

301 E Square Subhash Road, Vile Parle (East), Mumbai, Maharashtra, 400057

Year	History
1994	The company became a Public Limited Company by deleting restrictive clauses in its articles of association through a special resolution.
2003	The board approved the acquisition of Konarak Textile Industries Pvt. Ltd., making it a subsidiary of the company.
2008	The company created an email id for the grievance redressal division/compliance officer.
2015	The company changed its registered address to 301, E Square, Subhash Road, Vile Parle (East), Mumbai - 400 057.
2016	NGL Fine Chem was listed in Forbes Asia's 'Best Under A Billion' list.

Client Name	Order Side	QTY	Avg Price	Date
J S L ENTERPRISES	Buy	43471	238.35	12 Apr 2016
UPHAR HOMEFIN PRIVATE LIMITED	Sell	43471	238.35	12 Apr 2016
SANJAYKUMAR JAGDISHPRASAD PODDAR	Buy	36783	133.5	23 Jun 2015
SHAKTIMAN STEEL CASTING PVT LTD.	Sell	36783	133.5	23 Jun 2015
ADITYA DEVENDRA THAKKAR	Sell	34700	12.43	15 Mar 2013
BP FINTRADE PRIVATE LIMITED	Sell	39265	27.81	15 Jul 2010
BP FINTRADE PRIVATE LIMITED	Buy	39268	27.9	15 Jul 2010
ASHOK KUMAR BILGAIYAN	Sell	37548	27.4	15 Jul 2010
ARYA INVESTMENTS	Sell	38500	27.83	15 Jul 2010
ARYA INVESTMENTS	Buy	41000	27.9	15 Jul 2010

NGL Fine Chem Ltd News

NGL Fine Chem Q3 Net Profit Surges Over 11x YoY

NGL Fine Chem reported exceptional Q3 performance with consolidated net profit jumping to ₹157 million from ₹13 million year-on-year, while revenue grew 44% to ₹1.28 billion.

03 Feb 2026

co actions results

NGL Fine-Chem Company Secretary Resigns

NGL Fine-Chem Limited announces resignation of Company Secretary & Compliance Officer Mrs. Pallavi Pednekar effective January 23, 2026, to pursue external career opportunities.

05 Jan 2026

stocks

NGL Fine-Chem Reports 28.64% Revenue Growth in Q2FY26 Amid Demand Recovery

NGL Fine-Chem Limited reported revenue growth of 28.64% year-on-year to ₹120.26 crores in Q2FY26, driven by steady demand recovery across its veterinary API product portfolio and key markets including Latin America, West Asia, Europe, and India. The company's ongoing ₹160 crore capacity expansion project remains on schedule for Q4FY26 completion, with commercial production expected to begin in the second half of the next financial year following regulatory audits.

14 Nov 2025

earnings

NGL Fine-Chem Plans ₹250 Cr Capex to Double Capacity by FY26, Targets 15-18% Revenue Growth

NGL Fine-Chem announced a ₹250 crore capital expenditure plan for new plant commissioning by FY26 to double its manufacturing capacity, supported by a 30+ API portfolio across veterinary and specialty segments. The company aims for 15-18% revenue CAGR through export-led growth and margin improvement from backward integration, while strengthening its R&D pipeline for animal health and custom synthesis.

14 Nov 2025

stock

NGL Fine-Chem Limited Announces Quarterly Financial Results for Quarter Ended September 30, 2025

NGL Fine-Chem Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The board meeting was held on November 12, 2025, at the company's Mumbai office. The results were prepared pursuant to SEBI listing regulations and include a limited review report from statutory auditors. The financial statements cover both the parent company and its wholly owned subsidiary, Macrotech Polychem Private Limited. The results have been disseminated on the company's website and submitted to BSE and NSE stock exchanges.

13 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800

NGL Fine Chem Ltd

NGL Fine Chem Share Price Live Chart

Summary

Analysis

Financials

Ratios

Shareholding

Technical Analysis

Corporate Actions

Peer Comparison

NGL Fine Chem Ltd About

Contact

NGL Fine Chem Ltd Company History

Deals

NGL Fine Chem Ltd News